Effect of atorvastatin on lipopolysaccharide-induced expression of C- Reactive protein in human pulmonary epithelial cells

Journal of Central South University (Medical Sciences)

Volumn 34, Issue 2, 2009, Pages 104-108

  Wu, Shangjie ^a   Xing, Xiqian ^b   Gan, Ye ^a   Zhao, Shuiping ^a   Chen, Ping ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Yan'an Hospital   (China)

Author keywords

Atorvastatin; C Reactive protein; Chronic obstructive pulmonary diseases; Human pulmonary epithelial cells; Lipopolysaccharide

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; HEPTANOIC ACID DERIVATIVE; LIPOPOLYSACCHARIDE; MESSENGER RNA; PYRROLE DERIVATIVE;

ARTICLE; CELL LINE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; GENETICS; HUMAN; LUNG; METABOLISM; PATHOLOGY;

C-REACTIVE PROTEIN; CELL LINE; DOWN-REGULATION; EPITHELIAL CELLS; HEPTANOIC ACIDS; HUMANS; LIPOPOLYSACCHARIDES; LUNG; PYRROLES; RNA, MESSENGER;

EID: 62749168355     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gabay C, Kushner I. Acute - phase proteins and other systemic responses to inflammation [ J ]. N Engl J Med, 1999, 340( 17): 448-454.
2. Claus D, Osmand A, Gewurz H. Radioimmunoassay of human C - reactive protein and levels in normal sera [ J ]. J Lab Clin Med, 1976, 87( 1 ): 120-128.
3. Wouters E F M. A wasting disease [ M ] // Chronic obstructive lung disease. Voelkel NF, MacNee W. Hamilton: BC Dekker, 2002: 364-376.
4. Man S F, Connett J E, Anthonisen N R, et al. C - reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease [ J ]. Thorax, 2006, 61 ( 10 ): 849- 853.
5. de Torres J P, Cordoba - Lanus E, Lopez - Aguilar C, et al. C - reactive protein levels and clinically important predictive outcomes in stable COPD patients [ J ]. Eur Respir J, 2006, 27(5): 902-907.
6. WU Shangjie, CHEN Ping, JIANG Xinian, et al. C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases [ J ]. Journal of Central South University. Medical Sciences, 2005,30 ( 4 ): 444-446.
7. Jabs W J, Logering B A, Gerke P, et al. The kidney as a second site of human C - reactive protein formation in vivo [ J]. Eur J Immunol, 2003, 33 ( 1 ): 152-161.
8. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C - reactive protein with adiponectin in blood stream and adipose tissue [ J ]. Circulation, 2003, 107(5); 671-674.
9. Gould J M, Weiser J N. Expression of C - reactive protein in the human respiratory tract [ J ]. Infect Immun, 2001, 69 (3): 1747-1754.
10. Wu S J, Zhao S P; Clinical observation and expression of C - reactive protein by LPS-induced A549 cells in patients with chronic obstructive pulmonary disease [ J ]. Jounal of Central south university. Medical Sciences, 2005, 30(2): 207 - 210.
11. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4 444 patients with coronary heart disease; the Scandinavian Simvastatin Survival Study (4S) [ J]. Lancet, 1994, 344( 8934): 1383-1389.
12. Vaughan C J, Murphy M B, Buckley B M. Statins do more than just lower cholesterol [ J ]. Lancet, 1996, 348 (9034): 1079-1082.
13. Albert M A, Danielson E, Rifai N, et al. Effect of statin therapy on C - reactive protein levels: the pravastatin inflammation/CRP evaluation ( PRINCE): a randomized trial and cohort study[J]. JAMA, 2001, 286( 1 ): 64-70.
14. Nissen S E, Tuzcu E M, Schoenhagen P, et al. Reversal of atherosclerosis with aggressive lipid lowering ( REVERSAL ) investigators; statin therapy, LDL cholesterol, C - reactive protein, and coronary artery disease [ J ]. N Engl J Med, 2005, 352( 1 ): 29-38.
15. Ridker P M, Cannon C P, Morrow D, et al. Pravastatin or atorvastatin evaluation and infection therapy - thrombolysis in myocardial infarction 22 ( PROVE IT-TIMI 22 ) investigators; C - reactive protein levels and outcomes after statin therapy [ J ]. N Engl J Med, 2005, 352( 1 ): 20-28.
16. van Eeden S F, Tan W C, Suwa T, et al. Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants ( PM (10)) [J]. Am J Respir Crit Care Med, 2001, 164(5): 826-830.
17. Suresh M V, Singh S K, Agrawal A. Interaction of calcium- bound C-reactive protein with fibronectin is controlled by pH: in vivo implications [ J ]. J Biol Chem, 2004, 279 (50): 52552-52557.
18. Ramage L, Proudfoot L, Guy K. Expression of C - reactive protein in human lung epithelial cells and upregulation' by cytokines and carbon particles [ J ]. Inhal Toxicol, 2004,16 (9): 607-613.
19. Wu S J, Duan S, Zhao S P, et al. Atorvastatin reduces li- popolysaccharide - induced expression of cyclooxygenase - 2 in human pulmonary epithelial cells [ J ]. Respir Res, 2005, 6: 27.
20. 2 and IL-6 secretions in human pulmonary epithelial cells [ J ]. Journal of Central South University. Medical Sciences, 2004,29(2). 192-194.
21. Arnaud C, Burger F, Steffens S, et al. Statins reduce inter- leukin-6 -induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins [ J ]. Arterioscler Thromb Vase Biol, 2005, 25 ( 6 ): 1231-1236.
22. Ochrietor J D, Harrison K A, Zahedi K, et al. Role of STAT 3 and C/EBP in cytokine - dependent expression of the mouse serum amyloid P - component ( SAP ) and C - reactive protein ( CRP ) genes [ J ]. Cytokine, 2000, 12 ( 7 ): 888-899.